2:

Lucy Gately1,2, Katharine Drummond3,4, Anthony Dowling5,6

  • 1Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.

Cancers
|October 26, 2024
PubMed
概括

放射治疗后的化疗 (CRT) 改善了高风险的2级质瘤患者的无进展生存率. 现实世界的数据显示,随着时间的推移,CRT的使用增加了,但观察仍然很常见,突出了对生物标志物的需求,以指导治疗决策.